---
document_datetime: 2025-10-20 13:35:12
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/diacomit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: diacomit-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.2426821
conversion_datetime: 2025-12-30 21:03:19.348688
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Diacomit

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number         | Scope   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------------|---------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| PSUR / EMA/PSUR/0000248464 | - -     | 19/06/2025                          | 21/08/2025                                  | SmPC                             | Variation |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| In view of available data on risk from clinical trial(s) and spontaneous reports, the PRAC Rapporteur considers a causal relationship between stiripentol and pneumonia is at least a reasonable possibility. The PRAC Rapporteur concluded that the product information of products containing stiripentol should be amended accordingly.   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|